Analyze Diet

Topic:Equine Viral Arteritis

Equine Viral Arteritis (EVA) is a contagious viral disease affecting horses, caused by the equine arteritis virus (EAV). The virus primarily spreads through respiratory secretions and venereal transmission, impacting both the respiratory and reproductive systems of horses. Clinical signs of EVA can vary widely, from subclinical infections to more severe symptoms such as fever, nasal discharge, conjunctivitis, and swelling of limbs and genitalia. In pregnant mares, the virus can lead to abortion. EVA can be diagnosed through serological tests, virus isolation, and molecular techniques such as PCR. This page compiles peer-reviewed research studies and scholarly articles that explore the epidemiology, pathogenesis, diagnosis, and control measures of Equine Viral Arteritis in equine populations.
A novel subgroup among genotypes of equine arteritis virus: genetic comparison of 40 strains.
Journal of veterinary medicine. B, Infectious diseases and veterinary public health    May 7, 2005   Volume 52, Issue 3 112-118 doi: 10.1111/j.1439-0450.2005.00833.x
Hornyák A, Bakonyi T, Tekes G, Szeredi L, Rusvai M.The authors determined partial nucleic sequences of the variable regions of open-reading frame (ORF5) from 151 nucleotide to 668 nucleotide and deduced amino acid sequences of 518 nucleotide respectively of 20 equine arteritis virus (EAV) isolates. About 19 Hungarian and one Austrian EAV strains were subjected to sequence analysis, the further data of 20 EAV strains: six North American and 14 European were obtained from the GenBank. Comparative sequence analysis of the Hungarian EAV strains indicated that among the three variable regions the first has been affected mostly by point mutations. G...
Equine viral arteritis control scheme: a brief review with emphasis on laboratory aspects of the scheme in New Zealand.
New Zealand veterinary journal    March 16, 2005   Volume 52, Issue 2 82-84 doi: 10.1080/00480169.2004.36409
Horner GW.To review laboratory aspects of the equine viral arteritis (EVA) control scheme in New Zealand between 1989 and 2002. Methods: The optimisation and performance of the virus neutralisation test (VNT) for equine arteritis virus (EAV) antibody, and the cell culture test to detect EAV in semen were analysed. Laboratory data and control scheme results were reviewed. Results: Using optimised tests, it has been shown that antibody prevalence in Standardbred horses has steadily declined from 54% to <20%. Prevalences in Thoroughbred horses have remained at a low level of around 3%. The number of horses...
Binding of cellular proteins to the leader RNA of equine arteritis virus.
Virus genes    March 4, 2005   Volume 30, Issue 1 121-125 doi: 10.1007/s11262-004-4589-6
Archambault D, St-Louis MC, Martin S.The genome of equine arteritis virus (EAV) produces a 3' coterminal-nested set of six subgenomic (sg) viral RNAs during virus replication cycle, and each set possesses a common leader sequence of 206 nucleotides (nt) in length derived from the 5' end of the viral genome. Given the presence of the leader region within both genomic and sg mRNAs, it is likely to contain cis-acting signals that may interact with cellular or viral proteins for RNA synthesis. Gel mobility shift assays indicated that proteins in Vero cell cytoplasmic extracts formed complexes with the positive (+) and negative (-) st...
Diagnostic application of immunoperoxidase monolayer assay using monoclonal antibodies produced against equine arteritis virus 14-kDa nucleocapsid protein.
Hybridoma and hybridomics    February 3, 2005   Volume 23, Issue 6 368-372 doi: 10.1089/hyb.2004.23.368
Hornyák A, Dénes B, Szeredi L, Dencsö L, Rusvai M.Two monoclonal antibodies against the Bucyrus strain of equine arteritis virus (EAV) were produced, and according to immunoperoxidase reaction following Western blot of electrophoresed EAV structural proteins, they recognized the nucleocapsid (N) protein antigen (14-kDa protein). Besides reacting with the blotted polypeptide, the antibodies of the two clones (designated 1H1 and 4G6) selected from 576 have shown high affinity and specificity to intracellular virus antigen as well. Both antibodies reacted with the representatives of the different subtypes of equine arteritis virus providing a su...
Equine viral arteritis in a stallion.
The Veterinary record    January 22, 2005   Volume 156, Issue 1 28 
Manser P, Westcott D.No abstract available
Testing for equine arteritis virus.
The Veterinary record    December 3, 2004   Volume 155, Issue 20 647-648 
Cullinane AA.No abstract available
Rescue of disabled infectious single-cycle (DISC) equine arteritis virus by using complementing cell lines that express minor structural glycoproteins.
The Journal of general virology    November 24, 2004   Volume 85, Issue Pt 12 3709-3714 doi: 10.1099/vir.0.80443-0
Zevenhoven-Dobbe JC, Greve S, van Tol H, Spaan WJM, Snijder EJ.Equine arteritis virus (EAV) contains seven structural proteins that are all required to produce infectious progeny. Alphavirus-based expression vectors have been generated for each of these proteins to explore the possibilities for their constitutive expression in cell lines. This approach was successful for minor glycoproteins GP(2b), GP(3) and GP(4) and for the E protein. Subsequently, it was demonstrated that cell lines expressing these proteins could rescue EAV mutants that were disabled in the expression of the corresponding gene, resulting in the production of virus particles carrying t...
The immune response to equine arteritis virus: potential lessons for other arteriviruses.
Veterinary immunology and immunopathology    October 28, 2004   Volume 102, Issue 3 107-129 doi: 10.1016/j.vetimm.2004.09.003
Balasuriya UB, MacLachlan NJ.The members of the family Arteriviridae, genus Arterivirus, include equine arteritis virus (EAV), porcine reproductive and respiratory syndrome virus (PRRSV), lactate dehydrogenase-elevating virus (LDV) of mice, and simian hemorrhagic fever virus (SHFV). PRRSV is the newest member of the family (first isolated in North America and Europe in the early 1990s), whereas the other three viruses were recognized earlier (EAV in 1953, LDV in 1960, and SHFV in 1964). Although arterivirus infections are strictly species-specific, the causative agents share many biological and molecular properties, inclu...
Evidence that use of an inactivated equine herpesvirus vaccine induces serum cytotoxicity affecting the equine arteritis virus neutralisation test.
Vaccine    September 15, 2004   Volume 22, Issue 29-30 4117-4123 doi: 10.1016/j.vaccine.2004.02.052
Newton JR, Geraghty RJ, Castillo-Olivares J, Cardwell JM, Mumford JA.Several laboratories worldwide have recently experienced problems related to serum cytotoxicity with the equine arteritis virus (EAV) neutralisation test (VN) when using Office International des Epizooties (OIE) reference laboratory prescribed rabbit kidney (RK-13) indicator cells. Cytotoxicity can be mistaken for viral cytopathic effect and has led to increasing difficulties in test interpretation, consequently causing disruption to both equine breeding and disease surveillance. Results from experimental and field-derived data suggest that this serum cytotoxicity is associated with use of a t...
Phage display of the Equine arteritis virus nsp1 ZF domain and examination of its metal interactions.
Journal of virological methods    May 26, 2004   Volume 119, Issue 2 159-169 doi: 10.1016/j.jviromet.2004.04.002
Oleksiewicz MB, Snijder EJ, Normann P.A putative zinc finger (ZF) domain in the Equine arteritis virus (EAV) nsp1 protein was described recently to be required for viral transcription. The nsp1 ZF (50 aa) was expressed on the surface of M13KE gIII phage, fused to the N terminus of the phage pIII protein. To evaluate the functionality of the ZF domain, a binding assay was developed, based on the use of immobilized Ni(2+) ions (Ni-NTA). Phages displaying ZF bound significantly better to Ni-NTA than did phages displaying negative-control peptides, which also contained metal-coordinating residues. Also, binding of ZF-displaying phages...
The first isolation of equine arteritis virus in Argentina.
Revue scientifique et technique (International Office of Epizootics)    March 10, 2004   Volume 22, Issue 3 1029-1033 doi: 10.20506/rst.22.3.1458
Echeverría MG, Pecoraro MR, Galosi CM, Etcheverrigaray ME, Nosetto EO.This paper describes the first isolation of equine arteritis virus (EAV) in Argentina. The virus was isolated from the semen of an imported seropositive stallion held in isolation at a breeding farm in Tandil in the Buenos Aires Province. In addition, viral nucleic acid was detected in seminal plasma using the reverse-transcription polymerase chain reaction. The isolated virus was propagated in cell cultures and confirmed as EAV by indirect immunofluorescence and virus neutralisation, using a serum specific for the reference Bucyrus strain of EAV. As far as the authors are aware, this is the f...
Genetic characterization of equine arteritis virus during persistent infection of stallions.
The Journal of general virology    February 11, 2004   Volume 85, Issue Pt 2 379-390 doi: 10.1099/vir.0.19545-0
Balasuriya UBR, Hedges JF, Smalley VL, Navarrette A, McCollum WH, Timoney PJ, Snijder EJ, MacLachlan NJ.Equine arteritis virus (EAV) causes a persistent infection of the reproductive tract of carrier stallions. The authors determined the complete genome sequences of viruses (CW96 and CW01) that were present 5 years apart in the semen of a carrier stallion (CW). The CW96 and CW01 viruses respectively had only 85.6 % and 85.7 % nucleotide identity to the published sequence of EAV (EAV030). The CW96 and CW01 viruses had two 1 nt insertions and a single 1 nt deletion in the leader sequence, and a 3 nt coding insertion in ORF1a; thus their genomes included 12 708 nt as compared to the 12 704 nt in EA...
Equine arteritis virus in Irish thoroughbreds.
The Veterinary record    November 25, 2003   Volume 153, Issue 18 570 
Cullinane A.No abstract available
Equine viral arteritis in a newborn foal: parallel detection of the virus by immunohistochemistry, polymerase chain reaction and virus isolation.
Journal of veterinary medicine. B, Infectious diseases and veterinary public health    November 25, 2003   Volume 50, Issue 6 270-274 doi: 10.1046/j.1439-0450.2003.00684.x
Szeredi L, Hornyák A, Dénes B, Rusvai M.A 4-days-old foal died after a short course of respiratory syndrome and fever. Large areas of the alveoli, bronchioles and bronchi were partly or completely filled by hyaline membranes. Pronounced oedema and mild interstitial pneumonia were present and, in the small muscular arteries, fibrinoid necrosis and vasculitis or perivasculitis could be seen. Vasculitis was found in several other organs, and it was most severe in the thymus. The virus was detected in the lung, kidney and spleen using virus isolation and in the lung and spleen using polymerase chain reaction. The virus was also detected...
Virulent and avirulent strains of equine arteritis virus induce different quantities of TNF-alpha and other proinflammatory cytokines in alveolar and blood-derived equine macrophages.
Virology    October 14, 2003   Volume 314, Issue 2 662-670 doi: 10.1016/s0042-6822(03)00506-3
Moore BD, Balasuriya UB, Watson JL, Bosio CM, MacKay RJ, MacLachlan NJ.Equine arteritis virus (EAV) infects endothelial cells (ECs) and macrophages in horses, and many of the clinical manifestations of equine viral arteritis (EVA) reflect vascular injury. To further evaluate the potential role of EAV-induced, macrophage-derived cytokines in the pathogenesis of EVA, we infected cultured equine alveolar macrophages (AMphi), blood monocyte-derived macrophages (BMphi), and pulmonary artery ECs with either a virulent (KY84) or an avirulent (CA95) strain of EAV. EAV infection of equine AMphi, BMphi, and ECs resulted in their activation with increased transcription of g...
Lateral transmission of equine arteritis virus among Lipizzaner stallions in South Africa.
Equine veterinary journal    October 1, 2003   Volume 35, Issue 6 596-600 doi: 10.2746/042516403775467162
Guthrie AJ, Howell PG, Hedges JF, Bosman AM, Balasuriya UB, McCollum WH, Timoney PJ, MacLachlan NJ.A serological study conducted in 1995 revealed that 7 stallions at the Lipizzaner Centre, Gauteng, South Africa, were seropositive for antibody to equine arteritis virus (EAV). A Lipizzaner stallion imported into South Africa from Yugoslavia in 1981 had previously (1988) been confirmed to be an EAV carrier. Despite being placed under life-long breeding quarantine, EAV had been transmitted between stallions at the Lipizzaner Centre. Objective: To investigate the phylogenetic relationships between the strain of EAV shed in the semen of the original carrier stallion and strains recovered from the...
Detection of equine arteritis virus (EAV)-specific cytotoxic CD8+ T lymphocyte precursors from EAV-infected ponies.
The Journal of general virology    September 19, 2003   Volume 84, Issue Pt 10 2745-2753 doi: 10.1099/vir.0.19144-0
Castillo-Olivares J, Tearle JP, Montesso F, Westcott D, Kydd JH, Davis-Poynter NJ, Hannant D.Equine arteritis virus (EAV) causes a systemic infection in equids with variable outcome, ranging from subclinical infections to severe disease, and also has the capacity to induce abortion in pregnant mares and persistent infections in stallions. The serum virus-neutralizing antibody response that invariably develops in the infected animal lasts for many months or years and is believed to play an important role in virus clearance. However, very little is known about cellular immunity against EAV because of a lack of methods for evaluating these immune responses. In the present study, we descr...
Equine arteritis virus non-structural protein 1, an essential factor for viral subgenomic mRNA synthesis, interacts with the cellular transcription co-factor p100.
The Journal of general virology    August 15, 2003   Volume 84, Issue Pt 9 2317-2322 doi: 10.1099/vir.0.19297-0
Tijms MA, Snijder EJ.Non-structural protein 1 (nsp1), the N-terminal subunit of the replicase polyprotein of the arterivirus Equine arteritis virus (EAV), is essential for viral subgenomic mRNA synthesis, but fully dispensable for genome replication. However, at the molecular level, the role of nsp1 in EAV subgenomic mRNA synthesis is poorly understood. A yeast two-hybrid screen did not reveal interactions between EAV nsp1 and other viral non-structural proteins or the nucleocapsid protein, although both nsp1 and the nucleocapsid protein were found to form homomers. Subsequently, a yeast two-hybrid screen of a HeL...
Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain.
Journal of virology    July 15, 2003   Volume 77, Issue 15 8470-8480 doi: 10.1128/jvi.77.15.8470-8480.2003
Castillo-Olivares J, Wieringa R, Bakonyi T, de Vries AA, Davis-Poynter NJ, Rottier PJ.Equine arteritis virus (EAV) is an enveloped plus-strand RNA virus of the family Arteriviridae (order Nidovirales) that causes respiratory and reproductive disease in equids. Protective, virus-neutralizing antibodies (VNAb) elicited by infection are directed predominantly against an immunodominant region in the membrane-proximal domain of the viral envelope glycoprotein G(L), allowing recently the establishment of a sensitive peptide enzyme-linked immunosorbent assay (ELISA) based on this particular domain (J. Nugent et al., J. Virol. Methods 90:167-183, 2000). By using an infectious cDNA we h...
Testing for equine arteritis virus.
The Veterinary record    July 2, 2003   Volume 152, Issue 24 755 
Geraghty RJ, Newton JR, Castillo-Olivares J, Cardwell JM, Mumford JA.No abstract available
Differentiation of strains of equine arteritis virus of differing virulence to horses by growth in equine endothelial cells.
American journal of veterinary research    June 28, 2003   Volume 64, Issue 6 779-784 doi: 10.2460/ajvr.2003.64.779
Moore BD, Balasuriya UB, Nurton JP, McCollum WH, Timoney PJ, Guthrie AJ, MacLachlan NJ.To compare growth characteristics of strains of equine arteritis virus (EAV) of differing virulence to horses in rabbit kidney (RK)-13 cells and equine endothelial cells (EECs) cultured from the pulmonary artery of a foal. Methods: 13 strains of EAV, including 11 field isolates of differing virulence to horses; the highly virulent, horse-adapted Bucyrus strain; and the modified-live virus (MLV) vaccine derived from it. Methods: The growth characteristics of the 13 strains were compared in EECs and RK-13 cells. Viral nucleoprotein expression, cytopathogenicity, and plaque size were compared to ...
Testing for equine arteritis virus.
The Veterinary record    June 7, 2003   Volume 152, Issue 20 636 
Burr P, Snodgrass D.No abstract available
Formation of disulfide-linked complexes between the three minor envelope glycoproteins (GP2b, GP3, and GP4) of equine arteritis virus.
Journal of virology    May 14, 2003   Volume 77, Issue 11 6216-6226 doi: 10.1128/jvi.77.11.6216-6226.2003
Wieringa R, de Vries AA, Rottier PJ.Equine arteritis virus (EAV) is an enveloped, positive-stranded RNA virus belonging to the family Arteriviridae of the order NIDOVIRALES: Six transmembrane proteins have been identified in EAV particles: the nonglycosylated membrane protein M and the glycoprotein GP(5) (previously named G(L)), which occur as disulfide-bonded heterodimers and are the major viral envelope proteins; the unglycosylated small envelope protein E; and the minor glycoproteins GP(2b) (formerly designated G(S)), GP(3), and GP(4). Analysis of the appearance of the GP(2b), GP(3), and GP(4) proteins in viral particles by g...
Testing for equine arteritis virus.
The Veterinary record    May 2, 2003   Volume 152, Issue 15 478-479 
Geraghty RJ, Newton JR, Castillo-Olivares J, Cardwell JM, Mumford JA.No abstract available
The serologic response of horses to equine arteritis virus as determined by competitive enzyme-linked immunosorbent assays (c-ELISAs) to structural and non-structural viral proteins.
Comparative immunology, microbiology and infectious diseases    April 5, 2003   Volume 26, Issue 4 251-260 doi: 10.1016/S0147-9571(02)00054-1
Wagner HM, Balasuriya UB, James MacLachlan N.In an effort to further characterize the humoral immune response of horses to equine arteritis virus (EAV), direct and competitive enzyme-linked immunosorbent assays (c-ELISAs) were developed using monoclonal and polyclonal anti-sera to structural (G(L), N and M) and non-structural (nsp1) viral proteins. A nsp1-specific monoclonal antibody was produced to facilitate development of a c-ELISA to this protein. Data obtained using the various c-ELISAs confirm that the M protein is a major target of the antibody response of horses to EAV. However, none of the c-ELISAs that were developed were as se...
Use of an internal standard in a closed one-tube RT-PCR for the detection of equine arteritis virus RNA with fluorescent probes.
Veterinary research    March 27, 2003   Volume 34, Issue 2 165-176 doi: 10.1051/vetres:2002063
Westcott DG, King DP, Drew TW, Nowotny N, Kindermann J, Hannant D, Belák S, Paton DJ.Routine detection of equine arteritis virus (EAV) can be achieved by virus isolation (VI) in cell culture, or by the amplification of viral genome by molecular methods. To simplify molecular diagnosis, a number of different Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and RT-nested PCR (RT-nPCR) assays were compared, and a one-tube method was developed and optimised utilizing a fluorogenic probe (TaqMan). An artificial RNA template (Mimic) and associated probe were also constructed to provide in-tube validation of the RT-PCR system. To assess the utility of the RT-PCR TaqMan assay,...
Stable and long-lasting immune response in horses after DNA vaccination against equine arteritis virus.
Virus genes    November 7, 2002   Volume 25, Issue 2 159-167 doi: 10.1023/a:1020109801925
Giese M, Bahr U, Jakob NJ, Kehm R, Handermann M, Müller H, Vahlenkamp TH, Spiess C, Schneider TH, Schusse G, Darai G.Equine arteritis virus (EAV) is the causative agent of the equine viral arteritis. It is a small RNA virus with a linear, non-segmented plus RNA genome. EAV is a member of the Arteriviridae family that includes porcine reproductive and respiratory syndrome virus (PRSSV), simian haemorrhagic fever virus (SHFV) and lactate dehydrogenase virus (LDV). The viral transmission is via respiratory and reproductive routes. Clinical signs in horses vary, and severe infection can lead to abortions in pregnant mares or neonatal foal death. The aim of this study was to investigate the development of the imm...
Equine viral arteritis in the UK.
The Veterinary record    July 18, 2002   Volume 150, Issue 26 819-820 
Cardwell JM, Wood JL, Mumford JA, Geraghty RJ, Hillyer LL, Pascoe RJ.No abstract available
Growth characteristics of a highly virulent, a moderately virulent, and an avirulent strain of equine arteritis virus in primary equine endothelial cells are predictive of their virulence to horses.
Virology    July 3, 2002   Volume 298, Issue 1 39-44 doi: 10.1006/viro.2002.1466
Moore BD, Balasuriya UB, Hedges JF, MacLachlan NJ.Equine viral arteritis (EVA) is an endotheliotropic viral disease of horses caused by equine arteritis virus (EAV). Although there is only one serotype of EAV, there is marked variation in the virulence of different strains of the virus. The replication and cytopathogenicity of three well-characterized strains of EAV of different virulence to horses were compared in rabbit kidney (RK-13) and primary equine pulmonary artery endothelial cells (ECs). Viral protein expression, plaque size, and cytopathogenicity of all three viruses were similar in RK-13 cells, whereas two virulent strains of EAV w...
Importance of M-protein C terminus as substrate antigen for serodetection of equine arteritis virus infection.
Clinical and diagnostic laboratory immunology    May 3, 2002   Volume 9, Issue 3 698-703 doi: 10.1128/cdli.9.3.698-703.2002
Jeronimo C, Archambault D.Equine arteritis virus (EAV), an enveloped positive-stranded RNA virus, is the prototype of the arterivirus group. In a previous paper (A. Kheyar, S. Martin, G. St.-Laurent, P. J. Timoney, W. H. McCollum, and D. Archambault, Clin. Diagn. Lab. Immunol. 4:648-652, 1997), we have shown that the unglycosylated membrane (M) protein, which is composed of 162 amino acids (aa), is a major target of equine antibody to EAV. In order to determine the antigenic regions of the M protein, the cDNA encoding the M protein of EAV was inserted into the procaryotic expression vector pGEX-4T-1 to produce recombin...
1 4 5 6 7 8 13